Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
REGN

Regeneron Pharmaceuticals Inc. (REGN)

NASDAQ
$945.39
-$12.40
(-1.29%)
Previous Close: ⁦$957.76⁩
Market Closed

Last updated: ⁦2026-11-19 02:27:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Regeneron Pharmaceuticals Inc. (REGN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $945.39, with a market capitalization of $98.52B and a P/E ratio of 20.57. Over the past 52 weeks, its price has ranged from $591.52 to $991.73. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$98.52B

$957.25

$971.75

$943.23

$957.76

560.28K

803.79K

20.57

$991.73

$591.52

0.39%

2026-09-30

Regeneron Pharmaceuticals Inc. (REGN) Latest Closing Stock Price

Regeneron Pharmaceuticals Inc. (REGN) last closed at $945.39 as of 2026-11-19 01:00:00, down 1.29% ($12.40) from the previous close of $957.76.

During the latest regular trading session, REGN traded between $943.23 and $971.75, with a volume of 560.28K shares. The closing price was near the lower end and near the upper end of its 52-week range.

Regeneron Pharmaceuticals Inc. (REGN) 7-Day Stock Price Change

Over the past seven days, Regeneron Pharmaceuticals Inc. (REGN) moved from $919.96 to $945.39, representing a gain of 2.76% ($25.43).

The stock traded between $898.29 and $981.55 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 945.52 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

REGN 52-Week Price Position

Position in Range: 88.4%

52W Low$591.52
52W High$991.73

REGN is currently trading at $945.39, placing it 88.4% of the way from its 52-week low of $591.52 to its 52-week high of $991.73. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Regeneron Pharmaceuticals Inc. (REGN)?

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Regeneron Pharmaceuticals Inc. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
15,410
CEO
Leonard S. Schleifer
Founded
1988
Exchange
NASDAQ
Company Website

REGN Stock Events

View the latest dividend and stock split events for Regeneron Pharmaceuticals Inc.

Dividend
Ex-Dividend DateNov 20, 2026
Payment DateDec 3, 2026
Dividend Per Share$0.94

REGN News

Latest news related to Regeneron Pharmaceuticals Inc. and REGN stock.

  • Benzinga

    Regeneron Pharmaceuticals Obtains FDA Approval For Livsayis For The Treatment Of Generalized Myasthenia Gravis In Adult Patients Who Are Anti-Acetylcholine Receptor Antibody-Positive

    Read Full Article
  • Benzinga

    CytomX Therapeutics Announces $5M Milestone Payment From Regeneron Triggered By Preclinical Milestone In Collaboration

    Read Full Article
  • Massive

    Biotechnology Market Companies 2027 Analysis: Amgen, Gilead, Regeneron, Vertex and Moderna Post Strong 2026 Results as Billion-Dollar Deals Reshape a Market Headed for USD 6.34 Trillion by 2035

    The global biotechnology market, valued at USD 2.02 trillion in 2026, is projected to reach USD 6.34 trillion by 2035 at a 13.61% CAGR. Leading biotech companies including Amgen, Gilead, Regeneron, Vertex, and Moderna reported strong Q3 2026 results with revenue growth ranging from 8% to 36%. The sector experienced record dealmaking activity with major acquisitions totaling tens of billions of dollars, driven by patent expiries, strong cash flows, and strategic pipeline expansion in oncology, immunology, and advanced therapies.

    Read Full Article
  • Benzinga

    Regeneron Pharmaceuticals Says EC Approves Alternative, Flexible Dosing Schedule For Libtayo Across All Approved Skin, Lung And Cervical Cancer Indications

    Approval introduces an extended dosing regimen of Libtayo 700 mg given every six weeks, following initial 12 weeks of treatment with Libtayo 350 mg every three weeksAlso approved is an option of reducing subsequent

    Read Full Article
  • Benzinga

    Regeneron Drug Lowers Standing Heart Rate And Improves Symptoms In Heart Disease Study

    Regeneron reports Phase 2 PINNACLE trial data showing baloncibart reduces standing heart rate and improves symptoms in adults with POTS.

    Read Full Article

Ways to Trade REGN at MEXC

REGN MEXC RealStocks

Own real REGN shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

REGN Tokenized Stocks

Get REGN price exposure through a blockchain-based token.


Suitable for trading outside U.S. market hours.

  • Token tracks the REGN price
  • Trade 24/7
  • Trade on weekends and holidays

REGN Stock Futures

Trade REGN price movements with futures contracts.


Suitable for short-term positions.

  • Go long or short
  • Trade 24/7
  • Up to 20x leverage

How to Buy Regeneron Pharmaceuticals Inc. (REGN) Stock on MEXC

Eligible investors can buy real shares of Regeneron Pharmaceuticals Inc. (REGN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for REGN and Place Your Order
Step 3: Search for REGN and Place Your Order
Open the RealStocks trading page and search for REGN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Regeneron Pharmaceuticals Inc. (REGN) stock price today?
Regeneron Pharmaceuticals Inc. (REGN) is currently trading at $945.39, down 1.29% ($12.40) from the previous close of $957.76. Intraday prices update in real time during regular trading hours.
2.Is REGN stock going up or down today?
As of 2026-11-19 01:00:00, REGN is trading at $945.39, down 1.29% ($12.40) from its previous close of $957.76. The stock has traded between $943.23 and $971.75 during today’s regular session. Past price movements do not guarantee future results.
3.What is REGN pre-market price?
As of 2026-11-19 01:00:00, REGN is trading at $954.45 in pre-market trading, down 0.35% ($3.31) from the previous close of $957.76. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is REGN after-hours price?
As of 2026-11-19 01:00:00, REGN is trading at $954.00 in after-hours trading, up 0.91% ($8.61) from the regular-session close of $945.39. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is REGN stock trading now?
REGN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does REGN sit relative to its 52-week high and low?
Over the past 52 weeks, REGN has traded between a low of $591.52 and a high of $991.73. At $945.39, the stock is positioned 88.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Regeneron Pharmaceuticals Inc. in?
Regeneron Pharmaceuticals Inc. (REGN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Regeneron Pharmaceuticals Inc.'s market capitalization and where is it listed?
Regeneron Pharmaceuticals Inc. is listed on the NASDAQ exchange with a market capitalization of $98.52B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is REGN valued in terms of P/E ratio and EPS?
REGN trades at a P/E ratio of 20.57, based on trailing-twelve-month EPS of $46.57. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Regeneron Pharmaceuticals Inc. pay a dividend?
Regeneron Pharmaceuticals Inc. pays an indicated annual cash dividend of $3.69 per share, with a current dividend yield of 0.39% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Regeneron Pharmaceuticals Inc.

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to REGN, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

REGN Stock Calculator

Estimate the value between REGN shares and USD.

REGN Shares to USD

REGN Shares
REGN
REGN
USD
USD
USD

1.00 REGN shares = 945.391 USD

Calculations are estimates based on the latest available price and are for reference only.